Healthy Living

Research Reveals Cystic Fibrosis Severity Is Linked to Fungus

And more research will continue ahead

The new data presented by AIT Therapeutics will support the notion that nitric oxide is a viable and promising treatment option in helping to ward off MABSC lung infections and to improve patients’ symptoms. In the first poster, given the title “High-Dose Inhaled Nitric Oxide as a Potential Therapy Against Mycobacterium abscessus Lung Infection in Cystic Fibrosis”, the researchers will discuss the antimicrobial activity of nitric oxide on the multi-resistant MABSC. In the second poster, given the title “Treatment of Refractory Mycobacterium abscessus Lung Infection with Inhaled Intermittent Nitric Oxide”, the researchers will discuss a particular study involving an CF patient with an MABSC infection, who was given nitric oxide under the U.S. FDA’s compassionate use program.